Trials & Tribulations Pancreatic cancer survival edges up—as screening strategies emerge January 20, 2023Vol.49 No.03By Rosario Ligresti
Conversation with The Cancer Letter Jedd Wolchok: Weill Cornell’s path to NCI designation runs through Brooklyn and Queens January 13, 2023Vol.49 No.02By Paul Goldberg
Guest Editorial Ending cancer as we know it—for everyone—begins with the numbers January 13, 2023Vol.49 No.02By William L. Dahut
Cancer History ProjectConversation with The Cancer LetterFree Kay Dickersin: How NBCC started Project LEAD to teach science to breast cancer patients January 13, 2023Vol.49 No.02By Alexandria Carolan
FreeIn the Archives A new photo archive highlights NBCC’s impact in the 1990s January 13, 2023Vol.49 No.02
Conversation with The Cancer Letter What Ruben Mesa is thinking as he steps into one of the most-watched jobs in cancer January 06, 2023Vol.49 No.01By Paul Goldberg
FreeGuest Editorial A New Year’s greeting from Ukraine January 06, 2023Vol.49 No.01By Andriy Beznosenko
Capitol Hill NIH, NCI budgets up by more than 5% in FY23; FDA gets more robust accelerated approval authority January 06, 2023Vol.49 No.01By Matthew Bin Han Ong
FreeIn the Archives NCI oral history: J. Palmer Saunders on being tasked to investigate NCI’s Chemotherapy Program January 06, 2023Vol.49 No.01
FreeGuest Editorial S2302 Pragmatica-Lung Trial: Reaching more representative groups of patients with exciting clinical trials December 21, 2022Vol.48 No.46By Jhanelle E. Gray, Karen Reckamp, Mary Redman, Konstantin H. Dragnev, Ellen V. Sigal, Shakun Malik, Meg Mooney, James H. Doroshow and Charles D. Blanke
